StockNews.AI
TEM
StockNews.AI
189 days

Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24

1. Tempus AI will report Q4 and full year 2024 results on Feb 24, 2025. 2. CEO Eric Lefkofsky and CFO Jim Rogers will discuss earnings in the call. 3. The event highlights Tempus' leadership in AI and precision medicine. 4. Tempus has extensive multimodal data to support AI-driven healthcare solutions.

Earnings
-1.41%Current Return
VS
+0.01%S&P 500
$74.9402/11 09:42 AM EDTEvent Start
$73.8802/12 04:21 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Bullish?

The scheduled earnings report signals confidence and potential growth for TEM's stock.

How important is it?

The upcoming earnings report, coupled with key leadership participation, suggests strong potential market reactions.

Why Long Term?

Positive earnings reports can lead to sustained investor interest in TEM over time.

Related Companies

NASDAQ:TEM
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday, February 24, 2025. The company will hold the earnings conference call at 4:30 p.m. ET. The company’s quarterly earnings will be released the same day. The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be accessible through the events page of Tempus’ Investor Relations website. Alternatively, the call can be accessed via the following: Conference ID: 9601821 Domestic Dial-in Number: (888) 596-4144 International Dial-in Number: (646) 968-2525 Live Webcast: https://edge.media-server.com/mmc/p/6qbep94p About Tempus Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.

Related News